Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B
Last month
Deals
HHS focuses on 'transparency' in third-round IRA negotiation guidance
Last month
Law
Some generics, biosimilar drugmakers say they can withstand tariff impact
Last month
Manufacturing
Watch Post-Hoc Live: Trump's 'most favored nation' plan to cut drug prices
Last month
Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target
Last month
People
Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise
Last month
Lack of detail in Trump's drug price plan raises more questions than answers
Last month
Law
PBM overhaul and drug price negotiations make the cut in Republicans' tax bill
Last month
Law
Roche could rethink $50B US expansion plan if new policies 'harm' operations
Last month
Manufacturing
Updated: White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain
Last month
Trump says he'll sign order on 'most favored nation' drug price plans Monday
Last month
R&D
Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi
2 months ago
Manufacturing
Lonza says its US-based sites are in high demand as pharma tariffs near
2 months ago
Manufacturing
Illumina confirms SEC has closed investigation into $8B Grail deal
2 months ago
Diagnostics
Takeda announces handful of pipeline cuts in effort to ‘pivot resources’
2 months ago
Illumina forecasts $85M in tariff costs, decrease in China sales
2 months ago
Diagnostics
AstraZeneca loses appeals court fight over IRA drug price negotiations
2 months ago
Law
GSK awaits Nucala decision after FDA target date passes
2 months ago
FDA+
FDA grants Verastem first approval for rare ovarian cancer treatment
2 months ago
FDA+
FDA will convene vaccine advisors to discuss Covid strain updates
2 months ago
FDA+
Gilead reveals plans to put another $11B into US manufacturing
2 months ago
R&D
Manufacturing
Teva plans staff cuts as it commits to accelerating growth
2 months ago
Manufacturing
PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments
2 months ago
Manufacturing
FDA's ODAC will review drugs for four different cancers at meeting in May
2 months ago
FDA+
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page